Literature DB >> 30996808

Identification of Isoform 2 Acid-Sensing Ion Channel Inhibitors as Tool Compounds for Target Validation Studies in CNS.

Leda Ivanova Bencheva1, Marilenia De Matteo1, Luca Ferrante1, Marco Ferrara1, Adolfo Prandi1, Pietro Randazzo1, Silvano Ronzoni1, Roberta Sinisi1, Pierfausto Seneci1,2, Vincenzo Summa3, Mariana Gallo3, Maria Veneziano3, Antonella Cellucci3, Nausicaa Mazzocchi4, Andrea Menegon4, Romano Di Fabio1,3.   

Abstract

Acid-sensing ion channels (ASICs) are a family of ion channels permeable to cations and largely responsible for the onset of acid-evoked ion currents both in neurons and in different types of cancer cells, thus representing a potential target for drug discovery. Owing to the limited attention ASIC2 has received so far, an exploratory program was initiated to identify ASIC2 inhibitors using diminazene, a known pan-ASIC inhibitor, as a chemical starting point for structural elaboration. The performed exploration enabled the identification of a novel series of ASIC2 inhibitors. In particular, compound 2u is a brain penetrant ASIC2 inhibitor endowed with an optimal pharmacokinetic profile. This compound may represent a useful tool to validate in animal models in vivo the role of ASIC2 in different neurodegenerative central nervous system pathologies.

Entities:  

Year:  2019        PMID: 30996808      PMCID: PMC6466820          DOI: 10.1021/acsmedchemlett.8b00591

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  22 in total

Review 1.  Regulation and modulation of pH in the brain.

Authors:  Mitchell Chesler
Journal:  Physiol Rev       Date:  2003-10       Impact factor: 37.312

Review 2.  ASIC3 channels in multimodal sensory perception.

Authors:  Wei-Guang Li; Tian-Le Xu
Journal:  ACS Chem Neurosci       Date:  2010-11-12       Impact factor: 4.418

3.  Diarylamidines: high potency inhibitors of acid-sensing ion channels.

Authors:  Xuanmao Chen; Liyan Qiu; Minghua Li; Stefan Dürrnagel; Beverley A Orser; Zhi-Gang Xiong; John F MacDonald
Journal:  Neuropharmacology       Date:  2010-01-28       Impact factor: 5.250

Review 4.  ENaCs and ASICs as therapeutic targets.

Authors:  Yawar J Qadri; Arun K Rooj; Catherine M Fuller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

Review 5.  Design and screening of ASIC inhibitors based on aromatic diamidines for combating neurological disorders.

Authors:  Xuanmao Chen; Beverley A Orser; John F MacDonald
Journal:  Eur J Pharmacol       Date:  2010-09-18       Impact factor: 4.432

6.  Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cells.

Authors:  Wanda H Vila-Carriles; Gergely Gy Kovacs; Biljana Jovov; Zhen-Hong Zhou; Amit K Pahwa; Garrett Colby; Ogenna Esimai; G Yancey Gillespie; Timothy B Mapstone; James M Markert; Catherine M Fuller; James K Bubien; Dale J Benos
Journal:  J Biol Chem       Date:  2006-05-16       Impact factor: 5.157

7.  Mechanisms of non-steroid anti-inflammatory drugs action on ASICs expressed in hippocampal interneurons.

Authors:  Natalia A Dorofeeva; Oleg I Barygin; Alexander Staruschenko; Konstantin V Bolshakov; Lev G Magazanik
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

8.  Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential.

Authors:  Chien-Jung Huang; Alec Harootunian; Michael P Maher; Catherine Quan; Christopher D Raj; Ken McCormack; Randal Numann; Paul A Negulescu; Jesús E González
Journal:  Nat Biotechnol       Date:  2006-03-19       Impact factor: 54.908

Review 9.  Acid-sensing ion channels in pain and disease.

Authors:  John A Wemmie; Rebecca J Taugher; Collin J Kreple
Journal:  Nat Rev Neurosci       Date:  2013-07       Impact factor: 34.870

Review 10.  Acid-sensing ion channels (ASICs): therapeutic targets for neurological diseases and their regulation.

Authors:  Hae-Jin Kweon; Byung-Chang Suh
Journal:  BMB Rep       Date:  2013-06       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.